Figure S4. The efficiency of GBCDRlnc1 expression regulation of gallbladder cancer cells in vitro. (A) Relative expression of GBCDRlnc1 in Dox-resistant gallbladder cancer cells with si-GBCDRlnc1 was determined by qRT-PCR. (B) Relative expression of GBCDRlnc1 in Dox-resistant gallbladder cancer cells with pcDNA3.1-GBCDRlnc1 was determined by qRT-PCR. (C) The sensitivities of Dox-resistant gallbladder cancer cells under different transfection with GEM were determined by CCK-8 assay. (D) The sensitivities of the parental gallbladder cancer cells under different transfection with GEM were determined by CCK-8 assay. The mean ± SD of triplicate experiments were plotted, *P < 0.05, **P < 0.01, ***P < 0.001. (TIF 4499 kb
Figure S4. RIP assay confirmed that miR-143 was a target of PVT1. (a-b) The correlation among PVT1, ...
The expression of PI3K in GBM cells. The expression of PI3K was measured by Western blotting in GBM ...
Figure S1. Flow cytometry histograms for PD-L1 expression of 8 gastric cancer cell lines. PD-L1 was ...
Figure S6. Knockdown of PGK1 suppresses autophagy-associated chemoresistance of gallbladder cancer c...
Figure S5. GBCDRlnc1 inhibits PGK1 ubiquitination in gallbladder cancer cells in vitro. (A) Amount o...
Figure S2. Expression levels of 10 lncRNAs (A-B) and 6 mRNAs (C-D) by qRT-PCR in NOZ/Dox and NOZ/Ctr...
Figure S1. There is no difference in cell proliferation between Dox-resistant gallbladder cancer cel...
Table S3. 266 downregulated lncRNAs in NOZ/Dox with Fold Change > 2.0. (XLSX 29 kb
Figure S3. The information of GBCDRlnc1. (A) Nucleotide sequence of the full-length human GBCDRlnc1 ...
Table S1. Information of the qRT-PCR primer, siRNA and shRNA sequence. (XLSX 174 kb
Table S2. 457 upregulated lncRNAs in NOZ/Dox with Fold Change > 2.0. (XLSX 45 kb
Table S4. List of possible GBCDRlnc1-sence and GBCDRlnc1-antisence interacting proteins identified ...
Figure S1. The full-length sequence of HEGBC. Representative image of PCR products from 5’-RACE and ...
LINC00470 promoted GBM cell proliferation. CCK8 assay was performed to determine the viability of pr...
Figure S1. Expression and subcellular location of PVT1 in human GBC. cell lines. (a) PVT1 expression...
Figure S4. RIP assay confirmed that miR-143 was a target of PVT1. (a-b) The correlation among PVT1, ...
The expression of PI3K in GBM cells. The expression of PI3K was measured by Western blotting in GBM ...
Figure S1. Flow cytometry histograms for PD-L1 expression of 8 gastric cancer cell lines. PD-L1 was ...
Figure S6. Knockdown of PGK1 suppresses autophagy-associated chemoresistance of gallbladder cancer c...
Figure S5. GBCDRlnc1 inhibits PGK1 ubiquitination in gallbladder cancer cells in vitro. (A) Amount o...
Figure S2. Expression levels of 10 lncRNAs (A-B) and 6 mRNAs (C-D) by qRT-PCR in NOZ/Dox and NOZ/Ctr...
Figure S1. There is no difference in cell proliferation between Dox-resistant gallbladder cancer cel...
Table S3. 266 downregulated lncRNAs in NOZ/Dox with Fold Change > 2.0. (XLSX 29 kb
Figure S3. The information of GBCDRlnc1. (A) Nucleotide sequence of the full-length human GBCDRlnc1 ...
Table S1. Information of the qRT-PCR primer, siRNA and shRNA sequence. (XLSX 174 kb
Table S2. 457 upregulated lncRNAs in NOZ/Dox with Fold Change > 2.0. (XLSX 45 kb
Table S4. List of possible GBCDRlnc1-sence and GBCDRlnc1-antisence interacting proteins identified ...
Figure S1. The full-length sequence of HEGBC. Representative image of PCR products from 5’-RACE and ...
LINC00470 promoted GBM cell proliferation. CCK8 assay was performed to determine the viability of pr...
Figure S1. Expression and subcellular location of PVT1 in human GBC. cell lines. (a) PVT1 expression...
Figure S4. RIP assay confirmed that miR-143 was a target of PVT1. (a-b) The correlation among PVT1, ...
The expression of PI3K in GBM cells. The expression of PI3K was measured by Western blotting in GBM ...
Figure S1. Flow cytometry histograms for PD-L1 expression of 8 gastric cancer cell lines. PD-L1 was ...